Sign in
4

Changes in Ownership

STAAR SURGICAL CO Filed Acc 0001209191-21-032101

VP, Global Clinical, Medical sold 12,109 shares at an average $124.25 ($1,504,561)

  • VP, Global Clinical, Medical acquired 18,719 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Sale −1,349 $125.22 $168,922 8,342 D: show line 1 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise +7,200 $16.15 $116,280 15,542 D: show line 2 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise +2,534 $29.80 $75,513 18,076 D: show line 3 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise +3,462 $35.98 $124,563 21,538 D: show line 4 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise +5,523 $27.53 $152,048 27,061 D: show line 5 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Sale −10,760 $124.13 $1,335,639 16,301 D: show line 6 in the form
Open-market sales · 12,109 sh · avg $124.25 · $1,504,561

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise · Common Stock Options −7,200 0 D: show line 7 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise · Common Stock Options −2,534 750 D: show line 8 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise · Common Stock Options −3,462 8,564 D: show line 9 in the form
Hayashida Jon K. VP, Global Clinical, Medical 2021-05-10 Option exercise · Common Stock Options −5,523 9,774 D: show line 10 in the form
Loading xslF345X03/doc4.xml…